BridgeMD
New treatment option for AcuTENS
Official title Acu-TENS to Improve the Sleep Quality in People with Stroke
ClinicalTrials.gov ID: NCT05623137
What this study is testing
- What it's testing
- Post-stroke sleep disorder and motor/cognitive dysfunction are common complications that affect the quality of life of older patients. The proposed study investigates the effects of an acupuncture-like method applied to six bilateral acupoints on sleep quality, motor function and cognition in older adults with chronic stroke.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 85
You may be able to join if
- aged between 55 and 85 yrs;
- diagnosed with stroke by magnetic resonance imaging or computed tomographic scan longer than one year;
- able to walk 6-m independently;
- scored ≥18 but less or equal than 27 in mini-mental state examination (MMSE);
- self-reported poor sleep quality (PSQI, scores ≥ 6) in the past four weeks.
You likely can't join if
- have a cardiac pacemaker;
- have a severe disease that precludes the receipt of Acu-TENS;
- are taking medication that may affect measured outcomes;
- have skin lesions, infection, or inflammation near selected acupoints;
- are participating in other drug/treatment programs.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.